<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font25 { font-size : 25; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">[]. </span>
   <span class="font30">vitro </span>
   <span class="font25">virus </span>
   <span class="font21">treatment </span>
   <span class="font20">antiviral </span>
   <span class="font20">replication </span>
   <span class="font20">multifocal </span>
   <span class="font20">viral </span>
   <span class="font19">activity </span>
   <span class="font18">human </span>
   <span class="font17">leukoencephalopathy </span>
   <span class="font17">effect </span>
   <span class="font16">infection </span>
   <span class="font16">progressive </span>
   <span class="font16">used </span>
   <span class="font15">cells </span>
   <span class="font15">patients </span>
   <span class="font15">Mefloquine </span>
   <span class="font15">cell </span>
   <span class="font15">different </span>
   <span class="font15">antimalarial </span>
   <span class="font15">Chloroquine </span>
   <span class="font15">use </span>
   <span class="font15">drugs </span>
   <span class="font14">combination </span>
   <span class="font14">drug </span>
   <span class="font14">vivo </span>
   <span class="font14">effects </span>
   <span class="font14">{border-style </span>
   <span class="font14">ART </span>
   <span class="font14">infected </span>
   <span class="font14">Artesunate </span>
   <span class="font14">HIV </span>
   <span class="font14">patient </span>
   <span class="font14">px;} </span>
   <span class="font14">results </span>
   <span class="font14">study </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">malaria </span>
   <span class="font13">therapy </span>
   <span class="font13">treated </span>
   <span class="font13">HCMV </span>
   <span class="font13">disease </span>
   <span class="font13">inhibition </span>
   <span class="font13">Clin. </span>
   <span class="font13">DENV </span>
   <span class="font13">[,] </span>
   <span class="font13">cytomegalovirus </span>
   <span class="font13">showed </span>
   <span class="font13">PML </span>
   <span class="font13">[,]. </span>
   <span class="font13">efficacy </span>
   <span class="font13">model </span>
   <span class="font12">Artemisinin </span>
   <span class="font12">Infect. </span>
   <span class="font12">artesunate </span>
   <span class="font12">confirmed </span>
   <span class="font12">demonstrated </span>
   <span class="font12">studies </span>
   <span class="font12">DOX </span>
   <span class="font12">HIV- </span>
   <span class="font12">Virus </span>
   <span class="font12">chloroquine </span>
   <span class="font12">clinical </span>
   <span class="font12">mefloquine </span>
   <span class="font12">outcome </span>
   <span class="font12">CHIKV </span>
   <span class="font12">Med. </span>
   <span class="font12">NCT </span>
   <span class="font12">Res../j.antiviral... </span>
   <span class="font12">case </span>
   <span class="font12">colleagues </span>
   <span class="font12">quinine </span>
   <span class="font12">sulfate </span>
   <span class="font12">tested </span>
   <span class="font12">However, </span>
   <span class="font12">Neurol. </span>
   <span class="font12">activities </span>
   <span class="font12">compared </span>
   <span class="font12">conducted </span>
   <span class="font12">derivatives </span>
   <span class="font12">infections </span>
   <span class="font12">micromolar </span>
   <span class="font12">mirtazapine </span>
   <span class="font12">reduced </span>
   <span class="font12">viruses </span>
   <span class="font12">Doxycycline </span>
   <span class="font12">IAV </span>
   <span class="font12">Multifocal </span>
   <span class="font12">able </span>
   <span class="font12">active </span>
   <span class="font12">antiretroviral </span>
   <span class="font12">compounds </span>
   <span class="font12">dengue </span>
   <span class="font12">emerging </span>
   <span class="font12">hydroxyCQ </span>
   <span class="font12">inhibited </span>
   <span class="font12">number </span>
   <span class="font12">potential </span>
   <span class="font11">(Table </span>
   <span class="font11">EBOV </span>
   <span class="font11">Ebola </span>
   <span class="font11">HCV </span>
   <span class="font11">JCPyV </span>
   <span class="font11">ONEe./journal.pone. </span>
   <span class="font11">RNA </span>
   <span class="font11">Res. </span>
   <span class="font11">associated </span>
   <span class="font11">cells, </span>
   <span class="font11">data </span>
   <span class="font11">drug, </span>
   <span class="font11">effective </span>
   <span class="font11">hepatitis </span>
   <span class="font11">herpesvirus </span>
   <span class="font11">immune </span>
   <span class="font11">immunodeficiency </span>
   <span class="font11">influenza </span>
   <span class="font11">mechanisms </span>
   <span class="font11">mice </span>
   <span class="font11">published </span>
   <span class="font11">px; </span>
   <span class="font11">reported </span>
   <span class="font11">stem </span>
   <span class="font11">strains </span>
   <span class="font11">trials </span>
   <span class="font11">{font-family </span>
   <span class="font11">Agents </span>
   <span class="font11">Case </span>
   <span class="font11">Clinical </span>
   <span class="font11">Hydroxychloroquine </span>
   <span class="font11">Leukoencephalopathy </span>
   <span class="font11">S.D. </span>
   <span class="font11">[,,] </span>
   <span class="font11">acute </span>
   <span class="font11">artemisinin </span>
   <span class="font11">doxycycline </span>
   <span class="font11">entry </span>
   <span class="font11">font-size </span>
   <span class="font11">inhibit </span>
   <span class="font11">inhibits </span>
   <span class="font11">load </span>
   <span class="font11">observed </span>
   <span class="font11">potent </span>
   <span class="font11">reduction </span>
   <span class="font11">report </span>
   <span class="font11">resolution </span>
   <span class="font11">showing </span>
   <span class="font11">synthesis </span>
   <span class="font11">transplant </span>
   <span class="font11">trial </span>
   <span class="font11">using </span>
   <span class="font11">... </span>
   <span class="font11">Amodiaquine </span>
   <span class="font11">Chemother../AAC.- </span>
   <span class="font11">HIV-infected </span>
   <span class="font11">Med../internalmedicine.. </span>
   <span class="font11">Quinine </span>
   <span class="font11">Table </span>
   <span class="font11">[,,]. </span>
   <span class="font11">action </span>
   <span class="font11">activation </span>
   <span class="font11">agents </span>
   <span class="font11">anti-HIV- </span>
   <span class="font11">assay </span>
   <span class="font11">cells. </span>
   <span class="font11">cervical </span>
   <span class="font11">combined </span>
   <span class="font11">concentrations </span>
   <span class="font11">decrease </span>
   <span class="font11">described </span>
   <span class="font11">double; </span>
   <span class="font11">drugs. </span>
   <span class="font11">evaluated </span>
   <span class="font11">hydroxychloroquine </span>
   <span class="font11">infection, </span>
   <span class="font11">low </span>
   <span class="font11">new </span>
   <span class="font11">positive </span>
   <span class="font11">range </span>
   <span class="font11">reducing </span>
   <span class="font11">risperidone </span>
   <span class="font11">shown </span>
   <span class="font11">suggested </span>
   <span class="font11">Fatal </span>
   <span class="font11">Finally, </span>
   <span class="font11">HIV-positive </span>
   <span class="font11">HPV </span>
   <span class="font11">Neurovirol../s--- </span>
   <span class="font11">References </span>
   <span class="font11">Sulfonamides </span>
   <span class="font11">VSV </span>
   <span class="font11">Vero </span>
   <span class="font11">Virol../j.jcv... </span>
   <span class="font11">Viruses </span>
   <span class="font11">ZIKV </span>
   <span class="font11">Zika </span>
   <span class="font11">[,,,] </span>
   <span class="font11">[], </span>
   <span class="font11">blood </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cancer </span>
   <span class="font11">care </span>
   <span class="font11">caused </span>
   <span class="font11">chikungunya </span>
   <span class="font11">chronic </span>
   <span class="font11">death </span>
   <span class="font11">decreased </span>
   <span class="font11">did </span>
   <span class="font11">drugs, </span>
   <span class="font11">evaluation </span>
   <span class="font11">group </span>
   <span class="font11">high </span>
   <span class="font11">infection. </span>
   <span class="font11">inhibitory </span>
   <span class="font11">known </span>
   <span class="font11">leukoencephalopathy: </span>
   <span class="font11">literature </span>
   <span class="font11">obtained </span>
   <span class="font11">outcomes </span>
   <span class="font11">phase </span>
   <span class="font11">placebo </span>
   <span class="font11">plaque </span>
   <span class="font11">randomized </span>
   <span class="font11">regarding </span>
   <span class="font11">review </span>
   <span class="font11">severe </span>
   <span class="font11">significant </span>
   <span class="font11">solid; </span>
   <span class="font11">syndrome </span>
   <span class="font11">synergism </span>
   <span class="font11">type </span>
   <span class="font11">viruses, </span>
   <span class="font11">widely </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(Sarah </span>
   <span class="font10">(mouse) </span>
   <span class="font10">ART, </span>
   <span class="font10">Antimalarial </span>
   <span class="font10">Chinese </span>
   <span class="font10">DHA </span>
   <span class="font10">DNA </span>
   <span class="font10">Dihydroartemisinin </span>
   <span class="font10">Dis../ </span>
   <span class="font10">Drugs </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">HBV </span>
   <span class="font10">Health </span>
   <span class="font10">KSHV </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Treatment </span>
   <span class="font10">Virol../JVI.- </span>
   <span class="font10">[,,,,] </span>
   <span class="font10">activity, </span>
   <span class="font10">administration </span>
   <span class="font10">analogs </span>
   <span class="font10">anti-cytomegalovirus </span>
   <span class="font10">based </span>
   <span class="font10">bold </span>
   <span class="font10">cases </span>
   <span class="font10">cases, </span>
   <span class="font10">chemical </span>
   <span class="font10">coronavirus </span>
   <span class="font10">courier; </span>
   <span class="font10">derivatives, </span>
   <span class="font10">difference </span>
   <span class="font10">difficult </span>
   <span class="font10">dimer </span>
   <span class="font10">diseases </span>
   <span class="font10">dose-dependent </span>
   <span class="font10">doses </span>
   <span class="font10">double-blind, </span>
   <span class="font10">drug-resistant </span>
   <span class="font10">em; </span>
   <span class="font10">factors </span>
   <span class="font10">fever </span>
   <span class="font10">following </span>
   <span class="font10">herpes </span>
   <span class="font10">host </span>
   <span class="font10">improved </span>
   <span class="font10">improvement </span>
   <span class="font10">infectionJ. </span>
   <span class="font10">inhibitors </span>
   <span class="font10">latent </span>
   <span class="font10">malaria. </span>
   <span class="font10">measured </span>
   <span class="font10">microorganisms---t_Table </span>
   <span class="font10">multiple </span>
   <span class="font10">negative </span>
   <span class="font10">papillomavirus </span>
   <span class="font10">performed </span>
   <span class="font10">plasma </span>
   <span class="font10">polyomavirus </span>
   <span class="font10">possible </span>
   <span class="font10">present </span>
   <span class="font10">prevent </span>
   <span class="font10">primary </span>
   <span class="font10">production </span>
   <span class="font10">progression </span>
   <span class="font10">proposed </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">reports </span>
   <span class="font10">resistance </span>
   <span class="font10">risk </span>
   <span class="font10">standard </span>
   <span class="font10">strain </span>
   <span class="font10">sulfonamides </span>
   <span class="font10">systematic </span>
   <span class="font10">targeting </span>
   <span class="font10">therapeutic </span>
   <span class="font10">traditional </span>
   <span class="font10">treat </span>
   <span class="font10">valacyclovir </span>
   <span class="font10">versus </span>
  </p>
 </body>
</html>
